Aim:

To investigate the activation of nuclear factor-kappa B (NF-kappa B) and its function in glucocorticoid-induced Leydig cell apoptosis.

Methods:

The Leydig cells were isolated from male Sprague-Dawley rats (90 days of age) and were incubated with corticosterone (CORT, glucocorticoid in rat) for 6 h, 12 h and 24 h, respectively. The P65 subunit of NF-kappa B (NF-kappa B/P65) in nuclei and the inhibitor of NF-kappa B (Ikappa B) in cytoplasm were analyzed by Western-blotting. The Leydig cells were treated with anti-Fas antibody for 3 h followed by Western blotting to assay the changes of NF-kappa B/P65 in nuclei and in cytoplasm. The role of NF-kappa B in CORT-induced Leydig cell apoptosis was evaluated by observing the effects of NF-kappa B/P65 overexpression and inhibiting activation of NF-kappa B by 100 mol/L Pyrrolidine dithiocarbamate (PDTC) on this apoptosis.

Results:

The treatment of Leydig cells with CORT increased the levels of NF-kappa B/P65 in nuclei and decreased the levels of Ikappa B in cytoplasm. Following the Leydig cells were treated with anti-Fas antibody, the levels of NF-kappaB/P65 was increased in nuclei and decreased in cytoplasm. The CORT-induced Leydig cell apoptosis was inhibited by overexpressed NF-kappaB/P65 and was enhanced by incubation with PDTC.

Conclusion:

NF-kappa B is activated by increased FasL/Fas in CORT-induced Leydig cell apoptosis. NF-kappa B may play an anti-apoptotic role in this apoptosis.

References

1. Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649–83. | Article | PubMed | ISI | ChemPort |
2. Shishodia S, Aggarwal BB. Nuclear factor-kappa B activation: a question of life or death. J Biochem Mol Biol 2002; 35: 28–40. | PubMed | ISI | ChemPort |
3. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066–71. | Article | PubMed | ISI | ChemPort |
4. Chen F, Castranova V, Shi X, Demers LM. New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem 1999; 45: 7–17. | PubMed | ISI | ChemPort |
5. De Bosscher K, Vanden Berghe W, Haegeman G. The interplay between the glucocorticoid receptor and nuclear factor-kappa B or activator protein-1: molecular mechanisms for gene repression. Endocr Rev 2003; 24: 488–522. | Article | PubMed | ISI | ChemPort |
6. Hardy MP, Gao HB, Dong Q, Ge R, Wang Q, Chai WR, et al. Stress hormone and male reproductive function. Cell Tissue Res 2005; 322: 147–53. | Article | PubMed | ChemPort |
7. Gao HB, Tong MH, Hu YQ, Guo QS, Ge R, Hardy MP. Glucocorticoid induces apoptosis in rat leydig cells. Endocrinology 2002; 143: 130–8. | Article | PubMed | ChemPort |
8. Gao HB, Tong MH, Hu YQ, You HY, Guo QS, Ge RS, et al. Mechanisms of glucocorticoid-induced Leydig cell apoptosis. Mol Cell Endocrinol 2003; 199: 153–63. | Article | PubMed | ChemPort |
9. Gao HB, Shan LX, Monder C, Hardy MP. Suppression of endogenous corticosterone levels in vivo increases the steroidogenic capacity of purified rat Leydig cells in vitro. Endocrinology 1996; 137: 1714–8. | Article | PubMed | ChemPort |
10. Sriraman V, Rao VS, Sairam MR, Rao AJ. Effect of deprival of LH on Leydig cell proliferation: involvement of PCNA, cyclin D3 and IGF-1. Mol Cell Endocrinol 2000; 162: 113–20. | Article | PubMed | ChemPort |
11. Sriraman V, Sairam MR, Rao AJ. Evaluation of relative roles of LH and FSH in regulation of differentiation of Leydig cells using an ethane 1,2–dimethylsulfonate-treated adult rat model. J Endocrinol 2003; 176: 151–61. | Article | PubMed | ChemPort |
12. Klinefelter GR, Hall PF, Ewing LL. Effect of luteinizing hormone deprivation in situ on steroidogenesis of rat Leydig cells purified by a multistep procedure. Biol Reprod 1987; 36: 769–83. | Article | PubMed | ChemPort |
13. Payne AH, Downing JR, Wong KL. Luteinizing hormone receptors and testosterone synthesis in two distinct populations of Leydig cells. Endocrinology 1980; 106: 1424–9. | PubMed | ChemPort |
14. Klinefelter GR, Ewing LL. Optimizing testosterone production by purified adult rat Leydig cells in vitro. Cell Dev Biol 1988; 24: 545–9. | Article | ChemPort |
15. Schreiber S, Nikolaus S, Hampe J. Activation of nuclear factor kappa B inflammatory bowel disease. Gut 1998; 42: 477–84. | PubMed | ISI | ChemPort |
16. Imamura R, Konaka K, Matsumoto N, Hasegawa M, Fukui M, Mukaida N, et al. Fas ligand induces cell-autonomous NF-kappaB activation and interleukin-8 production by a mechanism distinct from that of tumor necrosis factor-alpha. J Biol Chem 2004; 279: 46415–23. | Article | PubMed | ChemPort |
17. Kreuz S, Siegmund D, Rumpf JJ, Samel D, Leverkus M, Janssen O, et al. NFkappaB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP. J Cell Biol 2004; 166: 369–80. | Article | PubMed | ISI | ChemPort |
18. Wilson JW, Wakeling AE, Morris ID, Hickman JA, Dive C. MCF-7 human mammary adenocarcinoma cell death in vitro in response to hormone-withdrawal and DNA damage. Int J Cancer 1995; 61: 502–8. | Article | PubMed | ChemPort |
19. SAS Institute, I., 2000. SAS/STAT® Users' Guide, SAS Institute Inc., Cary, NC.
20. Schmidt S, Rainer J, Ploner C, Presul E, Riml S, Kofler R. Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance. Cell Death Differ 2004; 11: S45–55. | Article | PubMed | ISI | ChemPort |
21. Shi J, Xu X, Li L, Zhang Z, Cheng W, Niu Y, et al. Inhibition of activation of nuclear factor-KappaBeta enhances apoptosis induced by chemotherapeutic drugs in P388 cell line. Zhonghua Yi Xue Za Zhi 2002; 82: 1050–3. | PubMed | ChemPort |
22. Barazzone-Argiroffo C, Pagano A, Juge C, Metrailler I, Rochat A, Vesin C, et al. Glucocorticoids aggravate hyperoxia-induced lung injury through decreased nuclear factor-kappa B activity. Am J Physiol Lung Cell Mol Physiol 2003; 284: L197–204. | PubMed | ChemPort |
23. Pazirandeh A, Xue Y, Okret S, Jondal M. Glucocorticoid resistance in thymocytes from mice expressing a T cell receptor transgene. Biochem Biophys Res Commun 2000; 276: 189–96. | Article | PubMed | ChemPort |
24. Ramdas J, Harmon JM. Glucocorticoid-induced apoptosis and regulation of NF-kappaB activity in human leukemic T cells. Endocrinology 1998; 139: 3813–21. | Article | PubMed | ISI | ChemPort |
25. Brostjan C, Anrather J, Csizmadia V, Stroka D, Soares M, Bach FH, et al. Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis. J Biol Chem 1996; 271: 19612–6. | Article | PubMed | ISI | ChemPort |
26. Han CW, Choi JH, Kim JM, Kim WY, Lee KY, Oh GT. Glucocorticoid-mediated repression of inflammatory cytokine production in fibroblast-like rheumatoid synoviocytes is independent of nuclear factor-kappaB activation induced by tumour necrosis factor alpha. Rheumatology (Oxford) 2001; 40:267–73. | Article | PubMed | ChemPort |
27. Slater AF, Kimland M, Jiang SA, Orrenius S. Constitutive nuclear NF kappa B/rel DNA-binding activity of rat thymocytes is increased by stimuli that promote apoptosis, but not inhibited by pyrrolidine dithiocarbamate. Biochem J 1995; 312:833–8. | PubMed | ISI | ChemPort |
28. Askenasy N, Yolcu ES, Yaniv I, Shirwan H. Induction of tolerance using Fas ligand: a double-edged immunomodulator. Blood 2005; 105: 1396–404. | Article | PubMed | ISI | ChemPort |
29. Brunner T, Wasem C, Torgler R, Cima I, Jakob S, Corazza N. Fas (CD95/Apo-1) ligand regulation in T cell homeostasis, cell-mediated cytotoxicity and immune pathology. Semin Immunol 2003; 15: 167–76. | Article | PubMed | ISI | ChemPort |
30. Fladmark KE, Gjertsen BT, Doskeland SO, Vintermyr OK. Fas/APO-1(CD95)-induced apoptosis of primary hepatocytes is inhibited by cAMP. Biochem Biophys Res Commun 1997; 232:20–5. | Article | PubMed | ChemPort |
31. Lin B, Williams-Skipp C, Tao Y, Schleicher MS, Cano LL, Duke RC, et al. NF-kappaB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type. Cell Death Differ 1999; 6: 570–82. | Article | PubMed | ISI | ChemPort |
32. Im E, Choi SH, Suh H, Choi YH, Yoo YH, Kim ND. Synthetic bile acid derivatives induce apoptosis through a c-Jun N-ter-minal kinase and NF-kappaB-dependent process in human cervical carcinoma cells. Cancer Lett 2005; 229: 49–57. | Article | PubMed | ChemPort |
33. Meyer M, Caselmann WH, Schluter V, Schreck R, Hofschneider PH, Baeuerle PA. Hepatitis B virus transactivator MHBst: activation of NF-kappa B, selective inhibition by antioxidants and integral membrane localization. EMBO J 1992; 11: 2991–3001. | PubMed | ISI | ChemPort |
34. Lauzurica P, Martinez-Martinez S, Marazuela M, Gomez del Arco P, Martinez C, Sanchez-Madrid F, et al. Pyrrolidine dithiocarbamate protects mice from lethal shock induced by LPS or TNF-alpha. Eur J Immunol 1999; 29: 1890–900. | Article | PubMed | ChemPort |

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.